Status:
RECRUITING
Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy
Lead Sponsor:
RenJi Hospital
Collaborating Sponsors:
Shanghai Jiao Tong University School of Medicine
Conditions:
Cognition
Eligibility:
All Genders
60+ years
Phase:
PHASE4
Brief Summary
To investigate the effect on cognition under sedation by Rimazole toluenesulfonatein elderly patients undergoing colonoscopy
Eligibility Criteria
Inclusion
- ASA I\~II
- patients will be treatmented by sedation under colonoscopy
- sign informed consent
Exclusion
- (1) Preoperative depression and cognitive impairment
- （2） Hearing or visual impairment;
- （3） Drug abuse, alcoholism or long-term use of antidepressants;
- （4） Cardiovascular and cerebrovascular accidents, neurological sequelae, or severe liver and kidney function damage occurred within 6 months
- （5） BMI \< 18, BMI \> 30
- （6） Confirmed or suspected allergy to the test drug
Key Trial Info
Start Date :
December 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05255211
Start Date
December 2 2021
End Date
December 30 2024
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongming Chen
Shanghai, Shanghai Municipality, China, 200127